5 Stocks Driving The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 90 points (0.6%) at 15,153 as of Tuesday, Sept. 10, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,842 issues advancing vs. 1,092 declining with 95 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.5%. Top gainers within the industry include DENTSPLY International ( XRAY), up 2.4%, Universal Health Services ( UHS), up 1.9%, HCA Holdings ( HCA), up 1.6%, Grifols ( GRFS), up 1.5% and ResMed ( RMD), up 1.3%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Varian Medical Systems ( VAR) is one of the companies pushing the Health Services industry higher today. As of noon trading, Varian Medical Systems is up $1.15 (1.6%) to $73.60 on average volume. Thus far, 527,779 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 713,600 shares. The stock has ranged in price between $72.63-$73.74 after having opened the day at $72.70 as compared to the previous trading day's close of $72.45.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.7 billion and is part of the health care sector. Shares are up 2.3% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Varian Medical Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

PerkinElmer Takes Cautious Approach to M&A

Here's How Health-Care Reform Will Affect This Cancer Care Company

Corporate Tax Reform Could Be a Bigger Deal for This Company Than the ACA

Here Are the Biotech Stocks Moving Ahead of the Opening Bell

PerkinElmer Medical Imaging Unit Sale Could Be in the Works